India's first intranasal vaccine for COVID-19 gets emergency use authorisation from DCGI

New Delhi : Bharat Biotech's intranasal COVID vaccine gets emergency use authorisation from Drug Controller General of India (DGCI) on Tuesday, informed Union Health Minister Dr Mansukh Mandaviya in a tweet.

Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by CDSCO for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation.

Informing that this will be India's first nasal vaccine for COVID-19, Union Health Minister, Dr Mansukh Mandaviya termed it as a ‘Big Boost to India's Fight Against COVID-19’.

He further informed that the step will further strengthen India's collective fight against the pandemic.

"India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji's leadership. With the science-driven approach & Sabka Prayas, we will defeat COVID-19," he added.